• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Modeling study reveals significant between-country disparities in tobacco use

byXiaozhou Liu
March 19, 2015
in Chronic Disease, Public Health
Reading Time: 3 mins read
Modeling study reveals significant between-country disparities in tobacco use
Share on FacebookShare on Twitter

1. During the most recent decade (2000-2010), a majority of countries saw a significant decrease in the prevalence of tobacco smoking.

2. Despite progress, only a minority of countries were projected to be on track to achieve their targets for tobacco control.

Evidence Rating Level: 2 (Good)           

Study Rundown: Tobacco smoking is a major risk factor for a variety of serious medical conditions, such as chronic obstructive lung disease, an increased risk of stroke and other cardiovascular diseases, and various types of cancer, to name just a few. As a result, reduction in the prevalence of tobacco smoking has been a public health priority around the world. The authors of this study analyzed tobacco smoking patterns from 1990 to 2010 in over 170 countries based on data from the WHO Comprehensive Information Systems for Tobacco Control. The authors then projected future tobacco use by performing a Bayesian hierarchical meta-regression modelling on the existing data. The study observed a decrease in tobacco smoking in a majority of countries, yet also noted significant between-country disparities. Also noteworthy was the observation that perhaps only a minority of countries were on track to reach their tobacco control targets. The comprehensive nature of this study provides powerful knowledge for public health officials in their efforts to tackle this significant public health challenge. However, the study does not take into account the newer variants of tobacco smoking that have only recently gained media attention, such as e-cigarettes.

The study was funded by Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports and Technology, Japan; Department of Health, Australia; Bloomberg Philanthropies. The funding sources had no role in the design, implementation, analysis, or writing of the study, or choice of journal.

Click to read the study in the Lancet

RELATED REPORTS

#VisualAbstract: Higher Nicotine Consumption Observed Among Youth with Attention-Deficit-Hyperactivity Disorder

Vaping and other tobacco products associated with greater risk of suicide attempts in children

Including e-cigarettes in smoking cessation counseling increases tobacco abstinence

Relevant Reading: Global effects of smoking, of quitting, and of taxing tobacco

In-Depth [retrospective cohort]: This study performed systematic assessments of trends for four tobacco smoking indicators – current tobacco smoking, daily tobacco smoking, current cigarette smoking, and daily cigarette smoking. The data about tobacco use prevalence was obtained from the WHO Comprehensive Information Systems for Tobacco Control and covered the time period from 1990 to 2014. In total, 26153 data points from 180 countries specific to country, year, sex and age were included in the final analyses.

From 2000 to 2010, 125 (72%) countries saw decreased prevalence in men, whereas 155 (87%) countries saw decreased prevalence in women. The study estimated that if the current trend persisted, there would be 1.1 billion smokers (95% credible interval, CI, 700 million to 1.6 billion) in 2025. The projection showed that only 43 (25%) countries for men and 93 (52%) countries for women will have probability of 95% or greater to observe a decrease in prevalence from 2010 to 2025 with current trends. There was significant geographical variation – high probability (≥95%) of decrease for most countries in the Americas, versus high probabilities of increase for about a third of countries in Africa and Eastern Mediterranean for men.

Additionally, projections based on current trends predicted that only 37 (21%) countries for men and 88 (49%) countries for women were on track to achieve their targets for tobacco control, with low-to-middle income countries particularly prone to having low target achievement probabilities.

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: tobacco
Previous Post

NSAID use effect on colorectal cancer risk influenced by genetics

Next Post

Radial artery access for invasive management of acute coronary syndrome reduces mortality and major bleeding [MATRIX Access trial]

RelatedReports

#VisualAbstract: Higher Nicotine Consumption Observed Among Youth with Attention-Deficit-Hyperactivity Disorder
StudyGraphics

#VisualAbstract: Higher Nicotine Consumption Observed Among Youth with Attention-Deficit-Hyperactivity Disorder

April 16, 2025
Smoking during pregnancy associated with aerobic fitness of children
Pediatrics

Vaping and other tobacco products associated with greater risk of suicide attempts in children

March 8, 2024
Active smoking cessation intervention may provide tangible results [Project CLIQ]
Public Health

Including e-cigarettes in smoking cessation counseling increases tobacco abstinence

March 7, 2024
#VisualAbstract: Electronic nicotine-delivery systems improve smoking cessation
StudyGraphics

#VisualAbstract: Electronic nicotine-delivery systems improve smoking cessation

February 21, 2024
Next Post
Appropriate use criteria for angiography may frequently miss obstructive coronary artery disease

Radial artery access for invasive management of acute coronary syndrome reduces mortality and major bleeding [MATRIX Access trial]

Novel biodegradable sirolimus-eluting stents non-inferior to durable everolimus-eluting stents [BIOSCIENCE trial]

Bypass surgery superior to stents for complex coronary disease [BEST trial]

Clindamycin and trimethoprim-sulfamethoxazole equally effective for uncomplicated skin infections

Clindamycin and trimethoprim-sulfamethoxazole equally effective for uncomplicated skin infections

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Video mental health care may have clinical advantages versus phone or in-person visits
  • Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring
  • Transanastomotic tubes not linked to anastomotic stricture after esophageal atresia repair
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.